Vanhove, B.; Poirier, N.; Fakhouri, F.; Laurent, L.; ’t Hart, B.; Papotto, P.H.; Rizzo, L.V.; Zaitsu, M.; Issa, F.; Wood, K.;
et al. Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies 2017, 6, 19.
https://doi.org/10.3390/antib6040019
AMA Style
Vanhove B, Poirier N, Fakhouri F, Laurent L, ’t Hart B, Papotto PH, Rizzo LV, Zaitsu M, Issa F, Wood K,
et al. Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies. 2017; 6(4):19.
https://doi.org/10.3390/antib6040019
Chicago/Turabian Style
Vanhove, Bernard, Nicolas Poirier, Fadi Fakhouri, Laetitia Laurent, Bert ’t Hart, Pedro H. Papotto, Luiz V. Rizzo, Masaaki Zaitsu, Fadi Issa, Kathryn Wood,
and et al. 2017. "Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders" Antibodies 6, no. 4: 19.
https://doi.org/10.3390/antib6040019
APA Style
Vanhove, B., Poirier, N., Fakhouri, F., Laurent, L., ’t Hart, B., Papotto, P. H., Rizzo, L. V., Zaitsu, M., Issa, F., Wood, K., Soulillou, J.-P., & Blancho, G.
(2017). Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies, 6(4), 19.
https://doi.org/10.3390/antib6040019